AU2002338734A1 - Use of phosphorodiesterase IV inhibitors - Google Patents
Use of phosphorodiesterase IV inhibitorsInfo
- Publication number
- AU2002338734A1 AU2002338734A1 AU2002338734A AU2002338734A AU2002338734A1 AU 2002338734 A1 AU2002338734 A1 AU 2002338734A1 AU 2002338734 A AU2002338734 A AU 2002338734A AU 2002338734 A AU2002338734 A AU 2002338734A AU 2002338734 A1 AU2002338734 A1 AU 2002338734A1
- Authority
- AU
- Australia
- Prior art keywords
- phosphorodiesterase
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10150517A DE10150517A1 (en) | 2001-10-12 | 2001-10-12 | Medicaments containing pyridazinone, thiadiazinone or oxadiazinone derivatives, used e.g. for treatment of osteoporosis, tumors, atherosclerosis, rheumatoid arthritis or multiple sclerosis |
| DE10150517.5 | 2001-10-12 | ||
| PCT/EP2002/010507 WO2003032993A1 (en) | 2001-10-12 | 2002-09-19 | Use of phosphorodiesterase iv inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002338734A1 true AU2002338734A1 (en) | 2003-07-03 |
| AU2002338734B2 AU2002338734B2 (en) | 2007-11-08 |
Family
ID=7702358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002338734A Ceased AU2002338734B2 (en) | 2001-10-12 | 2002-09-19 | Use of phosphorodiesterase IV inhibitors |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20040235845A1 (en) |
| EP (1) | EP1435958A1 (en) |
| JP (1) | JP2005505604A (en) |
| KR (1) | KR20050028900A (en) |
| CN (1) | CN1564687A (en) |
| AR (1) | AR037741A1 (en) |
| AU (1) | AU2002338734B2 (en) |
| CA (1) | CA2460135C (en) |
| CZ (1) | CZ2004457A3 (en) |
| DE (1) | DE10150517A1 (en) |
| HU (1) | HUP0401641A3 (en) |
| MX (1) | MXPA04002639A (en) |
| NO (1) | NO20041938L (en) |
| SK (1) | SK1652004A3 (en) |
| WO (1) | WO2003032993A1 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA06002521A (en) * | 2003-09-05 | 2006-06-20 | Altana Pharma Ag | Use of pde4 inhibitors for the treatment of diabetes mellitus. |
| US7494990B2 (en) | 2004-02-04 | 2009-02-24 | Nycomed Gmbh | 2-(piperidin-4-yl)-4,5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors |
| US20080227790A1 (en) * | 2004-02-04 | 2008-09-18 | Altana Pharma Ag | Pyridazinone Derivatives and their Use as Pde4 Inhibitors |
| CA2599376C (en) | 2005-03-08 | 2014-05-13 | Nycomed Gmbh | Roflumilast for the treatment of diabetes mellitus |
| DE102005055354A1 (en) * | 2005-11-21 | 2007-10-31 | Merck Patent Gmbh | Substituted 5-phenyl-3,6-dihydro-2-oxo-6H- [1,3,4] thiadiazines |
| DE102005055355A1 (en) * | 2005-11-21 | 2007-10-31 | Merck Patent Gmbh | thiadiazine derivatives 3,6-dihydro-2-oxo-6H- [1,3,4] |
| EP2063890A1 (en) * | 2006-09-07 | 2009-06-03 | Nycomed GmbH | Combination treatment for diabetes mellitus |
| CN105121439A (en) | 2013-02-19 | 2015-12-02 | 辉瑞公司 | Azabenzimidazole compounds as inhibitors of pde4 isozymes for the treatment of cns and other disorders |
| EP3172210B1 (en) | 2014-07-24 | 2020-01-15 | Pfizer Inc | Pyrazolopyrimidine compounds |
| KR102061952B1 (en) | 2014-08-06 | 2020-01-02 | 화이자 인코포레이티드 | Imidazopyridazine compounds |
| RU2626677C1 (en) * | 2016-03-09 | 2017-07-31 | Федеральное государственное автономное образовательное учреждение высшего образования "Уральский федеральный университет имени первого Президента России Б.Н. Ельцина" | Application of pharmaceutical composition of 2-morpholino-5-phenyl-6h-1,3,4-thiadiazine with ascorbic acid as means for alloxan diabetes correction |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4134893A1 (en) * | 1991-10-23 | 1993-04-29 | Merck Patent Gmbh | THIADIAZINONE |
| DE4310699A1 (en) * | 1993-04-01 | 1994-10-06 | Merck Patent Gmbh | Thiadiazinone |
| US5786354A (en) * | 1994-06-21 | 1998-07-28 | Celltech Therapeutics, Limited | Tri-substituted phenyl derivatives and processes for their preparation |
| DE19502699A1 (en) * | 1995-01-28 | 1996-08-01 | Merck Patent Gmbh | Arylalkyl-thiadiazinones |
| DE19514568A1 (en) * | 1995-04-20 | 1996-10-24 | Merck Patent Gmbh | Arylalkyl pyridazinones |
| DE19533975A1 (en) * | 1995-09-14 | 1997-03-20 | Merck Patent Gmbh | Arylalkyl diazinones |
| GB9525262D0 (en) * | 1995-12-11 | 1996-02-07 | Bayer Ag | Heterocyclylcarbonyl substituted benzofuranyl-ureas |
| DE19604388A1 (en) * | 1996-02-07 | 1997-08-14 | Merck Patent Gmbh | New aryl-alkyl diazinone derivatives |
| US5948911A (en) * | 1998-11-20 | 1999-09-07 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to thienopyrimidine derivatives |
-
2001
- 2001-10-12 DE DE10150517A patent/DE10150517A1/en not_active Withdrawn
-
2002
- 2002-09-19 JP JP2003535796A patent/JP2005505604A/en active Pending
- 2002-09-19 EP EP02777150A patent/EP1435958A1/en not_active Withdrawn
- 2002-09-19 CZ CZ2004457A patent/CZ2004457A3/en unknown
- 2002-09-19 MX MXPA04002639A patent/MXPA04002639A/en not_active Application Discontinuation
- 2002-09-19 CA CA2460135A patent/CA2460135C/en not_active Expired - Fee Related
- 2002-09-19 SK SK165-2004A patent/SK1652004A3/en not_active Application Discontinuation
- 2002-09-19 US US10/492,367 patent/US20040235845A1/en not_active Abandoned
- 2002-09-19 AU AU2002338734A patent/AU2002338734B2/en not_active Ceased
- 2002-09-19 CN CNA028198638A patent/CN1564687A/en active Pending
- 2002-09-19 HU HU0401641A patent/HUP0401641A3/en unknown
- 2002-09-19 KR KR1020047005415A patent/KR20050028900A/en not_active Application Discontinuation
- 2002-09-19 WO PCT/EP2002/010507 patent/WO2003032993A1/en not_active Application Discontinuation
- 2002-10-11 AR ARP020103824A patent/AR037741A1/en not_active Application Discontinuation
-
2004
- 2004-05-11 NO NO20041938A patent/NO20041938L/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002251266A1 (en) | Inhibitors of akt activity | |
| AU2002256418A1 (en) | Inhibitors of bace | |
| AU2002363005A1 (en) | Derivatives of uk-2a | |
| AU2002250394A1 (en) | Rho-kinase inhibitors | |
| AU2002245709A1 (en) | Rho-kinase inhibitors | |
| AU2003259749A1 (en) | 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors | |
| AU2002339348A1 (en) | Inhibition of STAT-1 | |
| AU2002337913A1 (en) | Glycosulfopeptide inhibitors and methods of use thereof | |
| AU2002238103A1 (en) | Use of beta-lactamase inhibitors as neuroprotectants | |
| AU2002338734A1 (en) | Use of phosphorodiesterase IV inhibitors | |
| AU2002306734A1 (en) | Inhibitors of plasmepsins | |
| HUP0401641A3 (en) | Use of substituted diazonine derivatives as phosphorodiesterase iv inhibitors | |
| AU2002304626A1 (en) | Sterilization of surfaces | |
| AU2002222933A1 (en) | Inhibitors of factor xa | |
| AU2002316552A1 (en) | Inhibitor of t cell activation | |
| AU2002305868A1 (en) | Inhibitors of reggamma | |
| AU2002221882A1 (en) | Use of 3-hydroxyl-3-methylglutaryl-coenzyme-a-reductase inhibitors | |
| AU4021700A (en) | Methods of use of beta1-integrin inhibitors | |
| AU2002258749A1 (en) | Inhibitors of glycosaminoglycans | |
| GB0100151D0 (en) | Methods of sputtering | |
| AU2002346812A1 (en) | Use of 1-phenyl-oxazolidine-2-one compounds as protease m inhibitors | |
| AU2003238034A1 (en) | Novel use of imidazotriazinones | |
| EP1238585B8 (en) | Use of esterquats | |
| AU2002328906A1 (en) | Inhibitors of polyq-aggregation | |
| AU2002305152A1 (en) | Inhibitors of akt activity |